أرسل هذا في رسالة قصيرة: A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies

  ______     ___     __   __     ___       _____  
 /_____//   / _ \\   \ \\/ //   / _ \\    / ___// 
 `____ `   / //\ \\   \   //   / //\ \\   \___ \\ 
 /___//   |  ___  ||  / . \\  |  ___  ||  /    // 
 `__ `    |_||  |_|| /_//\_\\ |_||  |_|| /____//  
 /_//     `-`   `-`  `-`  --` `-`   `-` `-----`   
 `-`